Snowball logo
logo
VRDN

Viridian Therapeutics Inc

VRDN NASDAQ
$29.25+$0.08  (0.27%)

Frequently asked questions

What sector does Viridian Therapeutics Inc (VRDN) operate in?

Viridian Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Viridian Therapeutics Inc (VRDN) current stock price?

As of the latest data, Viridian Therapeutics Inc stock price is $29.25, with a previous close of $29.17. Viridian Therapeutics Inc gained $0.08 in the last trading session, representing a 0.27% increase.

What is Viridian Therapeutics Inc (VRDN) current market capitalization?

Viridian Therapeutics Inc market cap is approximately 2.79 billion.

What is Viridian Therapeutics Inc (VRDN) Earnings Per Share (EPS)?

The trailing EPS is -$2.98, and the forward EPS is -$3.61.

What is Viridian Therapeutics Inc (VRDN) EBITDA?

Viridian Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -33.93 million.

Does Viridian Therapeutics Inc (VRDN) pay dividends?

No. Viridian Therapeutics Inc does not pay a dividend.

How did Viridian Therapeutics Inc (VRDN) perform in its most recent earnings report?

In the last report (September 30, 2025), Viridian Therapeutics Inc posted an EPS surprise of 64.33% and a revenue surprise of 502.21%.

When is Viridian Therapeutics Inc (VRDN) next earnings report?

Viridian Therapeutics Inc is expected to release its next earnings report on December 31, 2025.

What is Viridian Therapeutics Inc (VRDN) beta (volatility) score?

Viridian Therapeutics Inc has a beta of 0.945, meaning its volatility is roughly in line with the market.